ECB Faces a Difficult 2026-27 Balancing Act Between Inflation and Growth
Published . Updated .
Key takeaways
Market Call
Think this story will push the stock up or down over the next three trading days? Make a free call and see what other readers think. Points are play money with no cash value.
Get these market calls by email
The week's biggest market-moving stories, Congress trades and Trump posts, with the tickers they touch. Free, one email a week.
Free. We only use your email to send the digest and never sell or share it. See our privacy policy.
This report is about Europe.
Indirectly affected
- VGK Vanguard FTSE Europe ETF
Vanguard FTSE Europe ETF holds stocks listed in Europe, which this story is about (“ecb”).
- BWX SPDR Bloomberg International Treasury Bond ETF
SPDR Bloomberg International Treasury Bond ETF holds government bonds outside the US, which react to inflation and interest-rate news like this one in Europe
- EFA iShares MSCI EAFE ETF-0.7% 6d
iShares MSCI EAFE ETF is a broad fund of developed-market stocks that includes Europe
- ASML ASML Holding N.V-13.3% 10d
ASML Holding N.V (special industry machinery) is one of the largest Europe-based companies traded in the US, so news about Europe (“ecb”) reaches its shares.
- HSBC HSBC Holdings-1.9% 7d
HSBC Holdings (savings institution, federally chartered) is one of the largest Europe-based companies traded in the US, so news about Europe (“ecb”) reaches its shares.
- SHEL Shell
Shell (crude petroleum and natural gas) is one of the largest Europe-based companies traded in the US, so news about Europe (“ecb”) reaches its shares.
- NVS Novartis AG
Novartis AG (pharmaceutical preparations) is one of the largest Europe-based companies traded in the US, so news about Europe (“ecb”) reaches its shares.
Price reaction, T-5 to T+3
| Ticker | T-5 | T-3 | T-1 | T0 | T+1 | T+2 | T+3 |
|---|---|---|---|---|---|---|---|
| VGKPrices arriving within minutes | — | — | — | after close | after close | after close | after close |
| BWXPrices arriving within minutes | — | — | — | after close | after close | after close | after close |
| EFAPrices arriving within minutes | — | — | — | after close | after close | after close | after close |
| ASMLPrices arriving within minutes | — | — | — | after close | after close | after close | after close |
| HSBCPrices arriving within minutes | — | — | — | after close | after close | after close | after close |
| SHELPrices arriving within minutes | — | — | — | after close | after close | after close | after close |
| NVSPrices arriving within minutes | — | — | — | after close | after close | after close | after close |
Closing-price change versus T-1, the last close before the story. T0 to T+3 fill in after each market close. Prices: Alpaca IEX.
ECB Faces a Difficult 2026-27 Balancing Act Between Inflation and Growth kalkine.ca
Source: kalkine.ca
Congressional trades in the stocks in this story
- Sen. John Boozman sold EFA (jointly held), worth $1,001 - $15,000 on 9 Sep 2026. That is 72 days before publication. Filed 21 Oct 2026. View the filing.
- Rep. Kevin Hern sold Asml Holding (ASML) (jointly held), worth $15,001 - $50,000 on 23 Oct 2026. That is 28 days before publication. Filed 28 Oct 2026. View the filing.
- Rep. Kevin Hern sold Novartis Ag (NVS), worth $15,001 - $50,000 on 27 Aug 2026. That is 85 days before publication. Filed 25 Sep 2026. View the filing.
Public disclosure filings, not a recommendation. The filing link is the source document. News use of these reports still sits under 5 U.S.C. § 13107(c).
This story
12 out of 100
“ECB Faces a Difficult 2026-27 Balancing Act Between Inflation and Growth” scores 12 out of 100. The score uses 1 source.